| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 18,853,015 | 202,783 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 32,843 | 25,983 |
| Net change in cash, cash equivalents and restricted cash | 7,377,087 | -10,663,168 |
| Cash and cash equivalents at beginning of period | 15,998,174 | - |
| Cash and cash equivalents at end of period | 23,375,261 | - |
Dare Bioscience, Inc. (DARE)
Dare Bioscience, Inc. (DARE)